Stay ahead of CF progression, treat the cause early

With ORKAMBI®▼ (lumacaftor/ivacaftor) you can now treat cystic fibrosis in patients aged 6 years and older who are homozygous for the F508del mutation in the CFTR gene1

Find out more about ORKAMBI®

What are you looking for?

References

1. ORKAMBI® Summary of Product Characteristics. February 2018. Vertex Pharmaceuticals (Europe) Limited.